Evidence map›Paper›PMID 41458821›Full record

ArticleCureus2025

New-Onset Gambling Addiction Following Treatment for Psychosis With Cariprazine.

Muneeb Hashmi, Angel Nguyen, Hibah Ilyas

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Muneeb HashmiNaresh K. Vashisht College of Medicine, Texas A&M University, Bryan, USA.
Angel NguyenJohn Sealy School of Medicine, University of Texas Medical Branch at Galveston, Galveston, USA.
Hibah IlyasPsychiatry, Valley Health System, Las Vegas, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cariprazine is an atypical antipsychotic primarily used to treat schizophrenia and bipolar I disorder. Unlike most antipsychotics, it is effective in managing both the positive and negative symptoms of schizophrenia. However, it has recently been associated with impulse control disorders (ICDs) as a potential side effect. This case report describes a 42-year-old female patient with schizoaffective disorder who developed new-onset compulsive gambling following initiation of cariprazine therapy, despite well-controlled psychotic symptoms. After discontinuing cariprazine, the patient experienced a notable improvement in impulse control with complete cessation of gambling behavior. This report highlights the importance of careful monitoring for such side effects in patients receiving cariprazine and, to our knowledge, is the first to describe compulsive gambling associated with this medication.

Indexed as

addictionaripiprazoleatypical antipsychoticscariprazinecompulsive gamblingiatrogenic complicationimpulse control disorderpsychosis

Identifiers

PMID41458821
PMCPMC12738975

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.